Laura Prideaux

Laura Prideaux

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 June 2025 in Pathogens
Verified
Journal Article
Open access
PDF file
HSHayley Stratton
Hayley Stratton
PRPatrick Rosengren
Patrick Rosengren
TKToni Kinneally
Toni Kinneally
LPLaura Prideaux
Laura Prideaux
SSSimon Smith
Simon Smith
JHJosh Hanson
Josh Hanson
The case-fatality rate of severe leptospirosis can exceed 50%. This retrospective cohort study examined 111 individuals with laboratory-confirmed leptospirosis admitted to Cairns Hospital, a referral hospital in tropical Australia, between January 2015 and June 2024. We examined the patients’ demographic, clinical, laboratory and imaging findings at presentation and then correlated them with the patients’ subsequent clinical course. Severe disease was defined as the presence of pulmonary haemorrhage or a requirement for intensive care unit (ICU) admission. The patients’ median (interquartile range) age was 38 (24–55) years; 85/111 (77%) were transferred from another health facility. Only 13/111 (12%) had any comorbidities. There were 63/111 (57%) with severe disease, including 56/111 (50%) requiring ICU admission. Overall, 56/111 (50%) required vasopressor support, 18/111 (16%) needed renal replacement therapy, 14/111 (13%) required mechanical ventilation and 2/111 (2%) needed extracorporeal membrane oxygenation. Older age—but not comorbidity—was associated with the presence of severe disease. Hypotension, respiratory involvement, renal involvement and myocardial injury—but not liver involvement—frequently heralded a requirement for ICU care. Every patient in the cohort survived to hospital discharge. Leptospirosis can cause multi-organ failure in otherwise well young people in tropical Australia; however, patient outcomes are usually excellent in the country’s well-resourced health system.

19 May 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
HSHayley Stratton
Hayley Stratton
PRPatrick Rosengren
Patrick Rosengren
TKToni Kinneally
Toni Kinneally
LPLaura Prideaux
Laura Prideaux
SSSimon Smith
Simon Smith
JHJosh Hanson
Josh Hanson
The case-fatality rate of severe leptospirosis can exceed 50%. This retrospective cohort study examined 111 individuals with laboratory-confirmed leptospirosis admitted to Cairns Hospital, a referral hospital in tropical Australia, between January 2015 and June 2024. We examined the patients’ demographic, clinical, laboratory and imaging findings at presentation and correlated them with disease course. Severe disease was defined as the presence of pulmonary haemorrhage or a requirement for intensive care unit (ICU) admission. The patients’ median (interquartile range) age was 38 (24-55) years; 85/111 (77%) were transferred from another health facility. Only 13/111 (12%) had any comorbidities. There were 63/111 (57%) with severe disease, including 56/111 (50%) requiring ICU admission. Overall, 56/111 (50%) required vasopressor support, 18/111 (16%) required renal replacement therapy, 14/111 (13%) required mechanical ventilation and 2/111 (2%) required extracorporeal membrane oxygenation. Older age – but not comorbidity – was associated with the presence of severe disease. Hypotension, respiratory involvement, renal involvement and myocardial injury – but not liver involvement – frequently heralded a requirement for ICU care. Every patient in the cohort survived to hospital discharge. Leptospirosis can cause multi-organ failure in otherwise well young people in tropical Australia; however, outcomes are usually excellent in the country’s well-resourced health system.

29 January 2026 in Pathology
Verified
Journal Article
Closed access
LPLaura Prideaux
Laura Prideaux
NGNamraj Goire
Namraj Goire
SCSarah Crook
Sarah Crook
LDLinda Dreyer
Linda Dreyer
NSNorelle Sherry
Norelle Sherry
AMAndrew A. Mahony
Andrew A. Mahony